Literature DB >> 26865005

SETD1A induced miRNA network suppresses the p53 gene expression module.

Toshifumi Yae1,2, Ken Tajima1,2, Shyamala Maheswaran1,2.   

Abstract

Entities:  

Keywords:  BTG2; EZH2; SETD1A; cancer; cell cycle; epigenetics; histone modification; miRNA; p53

Mesh：

Substances：

Year:  2016        PMID： 26865005      PMCID： PMC5056611          DOI： 10.1080/15384101.2015.1130572

Source DB:  PubMed          Journal:  Cell Cycle        ISSN： 1551-4005            Impact factor:   4.534


× No keyword cloud information.
  7 in total

Review 1.  The COMPASS family of histone H3K4 methylases: mechanisms of regulation in development and disease pathogenesis.

Authors:  Ali Shilatifard
Journal:  Annu Rev Biochem       Date:  2012       Impact factor: 23.643

2.  The H3K4 methyltransferase Setd1a is first required at the epiblast stage, whereas Setd1b becomes essential after gastrulation.

Authors:  Anita S Bledau; Kerstin Schmidt; Katrin Neumann; Undine Hill; Giovanni Ciotta; Ashish Gupta; Davi Coe Torres; Jun Fu; Andrea Kranz; A Francis Stewart; Konstantinos Anastassiadis
Journal:  Development       Date:  2014-03       Impact factor: 6.868

Review 3.  EZH2 as a potential target in cancer therapy.

Authors:  Michael T McCabe; Caretha L Creasy
Journal:  Epigenomics       Date:  2014-06       Impact factor: 4.778

Review 4.  Histone lysine methylation dynamics: establishment, regulation, and biological impact.

Authors:  Joshua C Black; Capucine Van Rechem; Johnathan R Whetstine
Journal:  Mol Cell       Date:  2012-11-30       Impact factor: 17.970

5.  Unravelling mechanisms of p53-mediated tumour suppression.

Authors:  Kathryn T Bieging; Stephano Spano Mello; Laura D Attardi
Journal:  Nat Rev Cancer       Date:  2014-04-17       Impact factor: 60.716

Review 6.  The mammalian anti-proliferative BTG/Tob protein family.

Authors:  G Sebastiaan Winkler
Journal:  J Cell Physiol       Date:  2010-01       Impact factor: 6.384

7.  SETD1A modulates cell cycle progression through a miRNA network that regulates p53 target genes.

Authors:  Ken Tajima; Toshifumi Yae; Sarah Javaid; Oliver Tam; Valentine Comaills; Robert Morris; Ben S Wittner; Mingzhu Liu; Amanda Engstrom; Fumiyuki Takahashi; Joshua C Black; Sridhar Ramaswamy; Toshihiro Shioda; Molly Hammell; Daniel A Haber; Johnathan R Whetstine; Shyamala Maheswaran
Journal:  Nat Commun       Date:  2015-09-23       Impact factor: 14.919
  7 in total
  1 in total

1.  Global Reduction of H3K4me3 Improves Chemotherapeutic Efficacy for Pediatric Ependymomas.

Authors:  Rebecca Lewis; Yuping D Li; Lindsey Hoffman; Rintaro Hashizume; Gordan Gravohac; Gavin Rice; Nitin R Wadhwani; Chunfa Jie; Tatiana Pundy; Barbara Mania-Farnell; Chandra S Mayanil; Marcelo B Soares; Ting Lei; Charles D James; Nicolas K Foreman; Tadanori Tomita; Guifa Xi
Journal:  Neoplasia       Date:  2019-04-18       Impact factor: 5.715
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.